Showing results (121-130 of 282) with videos related to
Sort By:
Pageof 29
Clinical Lymphoma, Myeloma & Leukemia|July 14, 2018
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic SyndromeFevzi Firat Yalniz, Naval Daver, Katayoun Rezvani, et al.Cancer|August 27, 2009
Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemiaDeborah A Thomas, Hagop M Kantarjian, Wendy Stock, et al.International Journal of Molecular Sciences|September 22, 2017
Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid LeukemiaMaliha Khan, Jorge Cortes, Tapan Kadia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patientsApostolia-Maria Tsimberidou, Hagop M Kantarjian, Sijin Wen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantationYiming Chen, Jorge Cortes, Zeev Estrov, et al.Plos One|August 27, 2013
Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromesSophie Dimicoli, Yue Wei, Carlos Bueso-Ramos, et al.The Lancet. Haematology|December 22, 2015
Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: retrospective analysis of patient data from five clinical trialsPreetesh Jain, Hagop Kantarjian, Mona Lisa Alattar, et al.Cancer|January 19, 2012
Predicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score systemWei-Gang Tong, Alfonso Quintás-Cardama, Tapan Kadia, et al.Blood|August 9, 2011
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemiaFarhad Ravandi, Susan O'Brien, Jeffrey Jorgensen, et al.British Journal of Haematology|June 27, 2007
Biphenotypic acute leukaemia: a case seriesAhmed Aribi, Carlos Bueso-Ramos, Eli Estey, et al.Pageof 29